Dean Slocum

Dean Slocum

Auto-generated profile, based on publicly available information

Dean Slocum

University of Texas Health San Antonio

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Clinics in Shoulder and Elbow
Verified
Journal Article
Open access
PDF file
DMDavid Momtaz
David Momtaz
FAFarhan Ahmad
Farhan Ahmad
ASAaron Singh
Aaron Singh
ESEmilie Song
Emilie Song
DSDean Slocum
Dean Slocum
AAAdham Abdelfattah
Adham Abdelfattah
Background: Total elbow arthroplasty (TEA) is uncommon, but growing in incidence. Traditionally an inpatient operation, a growing number are performed outpatient, consistent with general trends in orthopedic surgery. The aim of this study was to compare TEA outcomes between inpatient and outpatient surgical settings. Secondarily, we sought to identify patient characteristics that predict the operative setting.Methods: Patient data were collected from the American College of Surgeons National Quality Improvement Program. Preoperative variables, including patient demographics and comorbidities, were recorded, and baseline differences were assessed via multivariate regression to predict operative setting. Multivariate regression was also used to compare postoperative complications within 30 days.Results: A total of 468 patients, 303 inpatient and 165 outpatient procedures, were identified for inclusion. Hypoalbuminemia (odds ratio [OR], 2.5; P=0.029), history of chronic obstructive pulmonary disorder or pneumonia (OR, 2.4; P=0.029), and diabetes mellitus (OR, 2.5; P=0.001) were significantly associated with inpatient TEA, as were greater odds of any complication (OR, 4.1; P<0.001) or adverse discharge (OR, 4.5; P<0.001) and decreased odds of reoperation (OR, 0.4; P=0.037).Conclusions: Patients undergoing inpatient TEA are generally more comorbid, and inpatient surgery is associated with greater odds of complications and adverse discharge. However, we found higher rates of reoperation in outpatient TEA. Our findings suggest outpatient TEA is safe, although patients with a higher comorbidity burden may require inpatient surgery.Level of evidence: III.

1 May 2023
Verified
Conference Paper
Closed access
ACA. Chang
A. Chang
ARA. Roy
A. Roy
LSL. Shi
L. Shi
RWR. Viazzo Winegar
R. Viazzo Winegar
DSD. Slocum
D. Slocum
PRPam Van Ry
Pam Van Ry

8 January 2026 in Geriatric Orthopaedic Surgery & Rehabilitation
Verified
Journal Article
Open access
ANAndrew Ni
Andrew Ni
AMAzophi Moffat
Azophi Moffat
JRJordan Robbins
Jordan Robbins
DSDean Slocum
Dean Slocum
ARAbhi Rashiwala
Abhi Rashiwala
RKRavi Karia
Ravi Karia
Introduction: Bisphosphonate medications reduce the risk of osteoporotic fragility fractures; however, prolonged use increases the risk of atypical femur fractures (AFF). As the population ages and the burden of osteoporosis rises, the relative incidence of AFFs is expected to grow. Current expert guidelines recommend discontinuing bisphosphonates and initiating alternative anti-fracture therapies (AFT), such as denosumab, teriparatide, or raloxifene, following an AFF to support skeletal health and reduce future fracture risk. However, it is unclear which patients receive these medications after an AFF. This study aims to identify demographics associated with the initiation of alternate osteoporosis therapies following an AFF. Methods: We conducted a retrospective cohort study using data from the TriNetX Registry to identify patients who were on bisphosphonate therapy that had an AFF. The primary outcome was initiation of teriparatide, denosumab, or raloxifene within one year after AFF. We compared patient demographics and baseline characteristics between those initiated on AFT after an AFF and those who were not. Pairwise comparisons of proportions were performed between the groups using two-proportion Z-tests with Bonferroni correction to account for multiple comparisons. Results: We identified 784 patients with AFFs following bisphosphonate use. 71 patients (9.5%) were initiated on AFT following the index fracture. Teriparatide (83.1%) was the most commonly prescribed AFT, followed by denosumab (21.9%), then raloxifene (≤14.1%). Patients initiated on AFT were more likely to have a previous fragility fracture (66.2% vs 45.2%, P < 0.001). Other patient demographics assessed did not show any significant differences. Discussion and Conclusion: Despite expert recommendations, AFT was initiated in only a small percentage of patients following AFFs. These findings highlight a significant care gap in secondary fracture prevention and underscore the need for a multidisciplinary approach, including coordination between endocrinology, orthopaedics, and primary care, to improve adherence to post-fracture osteoporosis management guidelines.

29 August 2024 in Global Surgical Education - Journal of the Association for Surgical Education
Verified
Journal Article
Closed access
PDF file
AAAngela G. Atkinson
Angela G. Atkinson
DSDean Slocum
Dean Slocum
JLJacob S. Luddington
Jacob S. Luddington
PRPatrick Shannon Ramsey
Patrick Shannon Ramsey
RMRahma Mungia
Rahma Mungia
JKJason W. Kempenich
Jason W. Kempenich